These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36472166)

  • 21. Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy.
    Li Y; Yang J; Gu G; Guo X; He C; Sun J; Zou H; Wang H; Liu S; Li X; Zhang S; Wang K; Yang L; Jiang Y; Wu L; Sun X
    Nano Lett; 2022 Feb; 22(3):963-972. PubMed ID: 35073699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferrocene-based multifunctional nanoparticles for combined chemo/chemodynamic/photothermal therapy.
    Yang J; Yang L; Li Q; Zhang L
    J Colloid Interface Sci; 2022 Nov; 626():719-728. PubMed ID: 35820207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferroptosis-Enhanced Cancer Immunity by a Ferrocene-Appended Iridium(III) Diphosphine Complex.
    Wang WJ; Ling YY; Zhong YM; Li ZY; Tan CP; Mao ZW
    Angew Chem Int Ed Engl; 2022 Apr; 61(16):e202115247. PubMed ID: 34965011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional "ball-rod" Janus nanoparticles boosting Fenton reaction for ferroptosis therapy of non-small cell lung cancer.
    Zhu G; Chi H; Liu M; Yin Y; Diao H; Liu Z; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
    J Colloid Interface Sci; 2022 Sep; 621():12-23. PubMed ID: 35447518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
    An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy.
    Asif K; Adeel M; Rahman MM; Caligiuri I; Perin T; Cemazar M; Canzonieri V; Rizzolio F
    J Mater Chem B; 2023 Apr; 11(14):3124-3135. PubMed ID: 36883303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis.
    Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L
    J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugated Polymer-Ferrocence Nanoparticle as an NIR-II Light Powered Nanoamplifier to Enhance Chemodynamic Therapy.
    He Y; Jin X; Guo S; Zhao H; Liu Y; Ju H
    ACS Appl Mater Interfaces; 2021 Jul; 13(27):31452-31461. PubMed ID: 34197086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer.
    Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Xu J; Liu W
    Theranostics; 2019; 9(21):6209-6223. PubMed ID: 31534546
    [No Abstract]   [Full Text] [Related]  

  • 30. Self-Assembling Porphyrins as a Single Therapeutic Agent for Synergistic Cancer Therapy: A One Stone Three Birds Strategy.
    Chen J; Chen F; Zhang L; Yang Z; Deng T; Zhao Y; Zheng T; Gan X; Zhong H; Geng Y; Fu X; Wang Y; Yu C
    ACS Appl Mater Interfaces; 2021 Jun; 13(24):27856-27867. PubMed ID: 34110146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intelligent design of iron-doped LDH nanosheets for cooperative chemo-chemodynamic therapy of tumors.
    Zhang L; Li G; Ouyang Z; Yang R; Gao Y; Cao X; Bányai I; Shi X; Guo R
    Biomater Sci; 2022 Apr; 10(8):2029-2039. PubMed ID: 35302125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parallel Lipid Peroxide Accumulation Strategy Based on Bimetal-Organic Frameworks for Enhanced Ferrotherapy.
    Xin H; Wang F; Luo R; Lei J
    Chemistry; 2021 Mar; 27(13):4307-4311. PubMed ID: 33377225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification of Lipid Peroxidation by Regulating Cell Membrane Unsaturation To Enhance Chemodynamic Therapy.
    Zhu Y; Gong P; Wang J; Cheng J; Wang W; Cai H; Ao R; Huang H; Yu M; Lin L; Chen X
    Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202218407. PubMed ID: 36708200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
    Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
    ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen peroxide self-sufficient and glutathione-depleted nanoplatform for boosting chemodynamic therapy synergetic phototherapy.
    Zhang H; Han R; Song P; Wei X; Hou Y; Yu J; Tang K
    J Colloid Interface Sci; 2023 Jan; 629(Pt A):103-113. PubMed ID: 36054988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tumor pH-responsive autocatalytic nanoreactor as a H
    Liu F; He T; Gong S; Shen M; Ma S; Huang X; Li L; Wang L; Wu Q; Gong C
    Acta Biomater; 2022 Dec; 154():510-522. PubMed ID: 36241016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy.
    Xing L; Liu XY; Zhou TJ; Wan X; Wang Y; Jiang HL
    J Control Release; 2021 Nov; 339():14-26. PubMed ID: 34547257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Cycling Free Radical Generator from LDH-Based Nanohybrids for Ferroptosis-Enhanced Chemodynamic Therapy.
    Yang X; Wang L; Guo S; Li R; Tian F; Guan S; Zhou S; Lu J
    Adv Healthc Mater; 2021 Sep; 10(18):e2100539. PubMed ID: 34319006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
    Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
    Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
    Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
    J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.